CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹25,644 Cr | ₹21,439 Cr | ₹18,057 Cr | ₹15,669 Cr | ₹13,537 Cr |
What is the latest Profit & Loss Account Balance ratio of CIPLA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹25,644 Cr |
| Mar2024 | ₹21,439 Cr |
| Mar2023 | ₹18,057 Cr |
| Mar2022 | ₹15,669 Cr |
| Mar2021 | ₹13,537 Cr |
How is Profit & Loss Account Balance of CIPLA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹25,644 Cr | 19.62 | |
| Mar2024 | ₹21,439 Cr | 18.73 | |
| Mar2023 | ₹18,057 Cr | 15.24 | |
| Mar2022 | ₹15,669 Cr | 15.75 | |
| Mar2021 | ₹13,537 Cr | - | |
Compare Profit & Loss Account Balance of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,435.6 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 2.4% | 4.5% | 18.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹90,806.8 Cr | 0.3% | 2.4% | -22.7% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -3.5% |
-1.5% |
-2.5% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses